Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Finished Goods (2020 - 2024)

Historic Finished Goods for IceCure Medical (ICCM) over the last 5 years, with Q4 2024 value amounting to $349000.0.

  • IceCure Medical's Finished Goods fell 3855.63% to $349000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $349000.0, marking a year-over-year decrease of 3855.63%. This contributed to the annual value of $349000.0 for FY2024, which is 3855.63% down from last year.
  • As of Q4 2024, IceCure Medical's Finished Goods stood at $349000.0, which was down 3855.63% from $568000.0 recorded in Q4 2023.
  • In the past 5 years, IceCure Medical's Finished Goods ranged from a high of $935000.0 in Q4 2022 and a low of $349000.0 during Q4 2024
  • For the 5-year period, IceCure Medical's Finished Goods averaged around $599600.0, with its median value being $568000.0 (2023).
  • As far as peak fluctuations go, IceCure Medical's Finished Goods soared by 12556.82% in 2021, and later crashed by 3925.13% in 2023.
  • Over the past 5 years, IceCure Medical's Finished Goods (Quarter) stood at $352000.0 in 2020, then surged by 125.57% to $794000.0 in 2021, then grew by 17.76% to $935000.0 in 2022, then plummeted by 39.25% to $568000.0 in 2023, then plummeted by 38.56% to $349000.0 in 2024.
  • Its Finished Goods was $349000.0 in Q4 2024, compared to $568000.0 in Q4 2023 and $935000.0 in Q4 2022.